Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Sep 13;35(10):3038. doi: 10.1038/s41375-021-01412-0

Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Andreas Neubauer 1,✉, Johannes Johow 2, Elisabeth Mack 1, Andreas Burchert 1, Damaris Meyn 3, Andrea Kadlubiec 1,2, Iuliu Torje 4, Hinnerk Wulf 5, Claus F Vogelmeier 6, Joachim Hoyer 7, Chrysanthi Skevaki 8, Ralf Michael Muellenbach 4, Christian Keller 9, Carmen Schade-Brittinger 2, Caroline Rolfes 4,5, Thomas Wiesmann 5
PMCID: PMC8436193  PMID: 34518646

Correction to: Leukemia 10.1038/s41375-021-01374-3

In the original article, the publisher missed to include the final contribution statement.

Caroline Rolfes and Thomas Wiesmann contributed equally to this paper as senior authors.

The original article has been updated.

Footnotes

Co-last authors Caroline Rolfes, Thomas Wiesmann

Articles from Leukemia are provided here courtesy of Nature Publishing Group

RESOURCES